Plandaí Biotechnology, Inc. (PLPL)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 15.63 Million | 558.11 Thousand | 6.96 Million | -6675.00 | - | -1.09 Million |
| Net Income | 16.02 Million | -19.8 Million | 6.82 Million | -396.75 Thousand | -83.48 Thousand | -4 Million |
| Depreciation & Amortization | - | - | - | - | - | 534.68 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -389.31 Thousand | 43.2 Thousand | 100.65 Thousand | 104.9 Thousand | 83.48 Thousand | 391.15 Thousand |
| Other non-cash items | - | 19.75 Million | -6.92 Million | 255.18 Thousand | - | 2.99 Million |
| Investing Cash Flow | -100 Thousand | - | - | - | - | 80.81 Thousand |
| Investments in PPE | -3.25 | - | - | - | - | -58.06 Thousand |
| Acquisitions | - | - | - | - | - | 138.87 Thousand |
| Investment purchases | -100 Thousand | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -15.53 Million | - | - | 6675.00 | - | 1.04 Million |
| Debt repayment | -104.82 Thousand | - | - | -6675.00 | - | -875.06 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -3.92 Million | - | - | - | - | - |
| Common Stock Issuance | 3.66 Million | - | - | - | - | 167.88 Thousand |
| Other Financing Activities | -15.38 Million | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | 5609.00 |
| Accounts payables | - | 25.21 Thousand | 24.27 Thousand | 30 Thousand | - | 36.62 Thousand |
| Inventory | - | - | - | - | - | 14.86 Thousand |
| Other working capital | -389.31 Thousand | 17.99 Thousand | 76.37 Thousand | 74.9 Thousand | 83.48 Thousand | 334.05 Thousand |
| Cash at beginning of period | - | - | - | - | 6896.00 | 12.91 Thousand |
| Cash at end of period | - | 558.11 Thousand | 6.96 Million | - | 6896.00 | 6896.00 |
| Capital Expenditure | -3.25 | - | - | - | - | -58.06 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 558.11 Thousand | 6.96 Million | - | - | -6019.00 |
| Free Cash Flow | 15.63 Million | 558.11 Thousand | 6.96 Million | -6675.00 | - | -1.15 Million |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.59 Million | 217.03 Thousand | -209.55 Thousand | 19.61 Million | -19.8 Million | -20.08 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -2846.07 | -394.86 Thousand | 2267.00 | 6126.00 | 43.2 Thousand | 4030.00 |
| Other non-cash items | 19.41 Million | 1.00 | 207.18 Thousand | -19.62 Million | 19.75 Million | 20.07 Million |
| Investing Cash Flow | -100 Thousand | - | - | - | - | - |
| Investments in PPE | -3.12 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -100 Thousand | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -15.71 Million | 177.82 Thousand | - | - | - | - |
| Debt repayment | -100 Thousand | -4825.00 | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -3.92 Million | - | - | - | - | - |
| Common Stock Issuance | 3.66 Million | - | - | - | - | - |
| Other Financing Activities | -15.56 Million | 173 Thousand | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | 100.00 | 3960.00 | 25.21 Thousand | 1001.00 |
| Inventory | - | - | - | - | - | - |
| Other working capital | -2846.07 | -394.86 Thousand | 2167.00 | 2166.00 | 17.99 Thousand | 3029.00 |
| Cash at beginning of period | - | - | - | - | - | 410.00 |
| Cash at end of period | - | - | -100.00 | -3960.00 | 558.11 Thousand | - |
| Capital Expenditure | -3.12 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | -100.00 | -3960.00 | 558.11 Thousand | -410.00 |
| Free Cash Flow | 15.81 Million | -177.82 Thousand | -100.00 | -3960.00 | 558.11 Thousand | -410.00 |
KIRLOSIND
DOM
0456
009270
VIDA
THVB